206
Views
0
CrossRef citations to date
0
Altmetric
Original research

The combined use of D-dimer testing and the neutrophil-to-lymphocyte ratio in the early differential diagnosis of aortic dissection

ORCID Icon, , , , &
Pages 347-355 | Received 17 Oct 2021, Accepted 24 Mar 2023, Published online: 29 Mar 2023
 

ABSTRACT

Background

The study aimed to ascertain whether a diagnostic strategy combining D-dimer with the neutrophil-to-lymphocyte ratio (NLR) could improve the discriminative performance for aortic dissection (AD).

Research design and methods

Baseline levels of D-dimer and NLR were measured in patients suspected of AD. The diagnostic performance and clinical usefulness of D-dimer, NLR, and their combination were assessed and compared using receiver operating characteristics (ROC) curve analysis, logistic regression analysis, net reclassification improvement (NRI), integrated discrimination improvement (IDI), and decision curve analysis (DCA).

Results

The levels of D-dimer and NLR were both significantly higher in AD patients. The combined use displayed good discriminatory performance with an area under ROC curve (AUC) of 0.869, which was preferable to that of D-dimer. Although no meaningful improvement was found in the AUC by comparison with NLR alone, the combined use could significantly improve the discrimination power with a continuous NRI of 60.0% and an IDI of 4.9%. DCA demonstrated that the net benefit of the combined use was preferred over that of either single test.

Conclusions

The combined use of D-dimer and NLR could improve the discriminatory efficiency for AD with the potential in clinical application. This study may provide a novel diagnostic strategy for AD. More studies need to be done to confirm the findings of this study.

List of abbreviations

AD=

aortic dissection

AMI=

acute myocardial infarction

PE=

pulmonary embolism

NLR=

the neutrophil-to-lymphocyte ratio

CTA=

computed tomographic angiography

WBC=

white blood cell

HGB=

hemoglobin

PLT=

platelet

MPV=

mean platelet volume

FIB=

fibrinogen

CK=

creatine kinase

ALT=

alanine aminotransferase

AST=

aspartate transaminase

Glu=

glucose

Cr=

creatinine

CRP=

C-reactive protein

hs-cTnT=

high sensitivity cardiac troponin T

ROC=

receiver operating characteristic

AUC=

the area under the ROC curve

LR=

likelihood ratio

PV=

predictive value

NRI=

net reclassification improvement

IDI=

integrated discrimination improvement

DCA=

decision curve analysis

IMH=

intramural hematoma

PAU=

penetrating aortic ulcer

OR=

odds ratio

CI=

confidence interval

AAS=

acute aortic syndrome

Declaration of interest

The authors have no relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript. This includes employment, consultancies, honoraria, stock ownership or options, expert testimony, grants or patents received or pending, or royalties. The authors declare no competing interests.

Authors’ contributions

Conception and design: H.X. Zhang and M. Hou; Extraction and collection of data: H.X. Zhang, N. Yuan, and J. Guo; Analysis and interpretation of data: All authors; Manuscript writing: H.X. Zhang; Final approval of manuscript: All authors.

Reviewer disclosures

Peer reviewers on this manuscript have no relevant financial or other relationships to disclose.

Availability of data

All data in this study may be available from the corresponding author upon reasonable requests.

Additional information

Funding

This paper was not funded.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.